Figure 2.
TMB in SCLCs from patients treated with immunotherapy who did or did not develop irAEs. irAE, immune-related adverse event; TMB, tumor mutational burden.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.